Three Key Dynamics to Understand for Canadian Market Access
With pharmaceutical spending forecasted to be $39.8 billion CAD ($30.2B USD) for 2018 the Canadian market can offer significant opportunity for pharmaceutical manufacturers, but only if they are able to understand the nuances of the country’s unique regulatory, market access, and customer needs. There is a perception that the majority of Canada’s healthcare policies—and coverage—exist at the national level. But Canada is a mixed market. Sandra Anderson, Vice President, Consulting and Business Development shared her perspective with PharmaExec.